Guofeng Cheng Selected Research

Guofeng Cheng Research Topics

Disease

25	Infections 01/2022 - 02/2005
15	Schistosomiasis (Bilharziasis) 01/2022 - 03/2010
5	Virus Diseases (Viral Diseases) 02/2008 - 09/2003
4	Schistosomiasis japonica 01/2022 - 04/2015
4	Neoplasms (Cancer) 01/2021 - 12/2013
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2019
1	Fibrosis (Cirrhosis) 08/2021
1	Hyperplasia 08/2021
1	Inflammation (Inflammations) 08/2021
1	Opisthorchiasis 08/2021
1	Genetic Translocation (Chromosomal Translocation) 01/2021
1	Chronic Hepatitis C 01/2016
1	Reinfection 11/2014
1	Parasitic Diseases (Parasitic Disease) 11/2014
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2014
1	Diarrhea 01/2014
1	Pathologic Processes 01/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2012
1	Starvation 12/2012
1	Hepatitis C 07/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2008
1	Insulinoma 11/2008
1	Hepatocellular Carcinoma (Hepatoma) 05/2007

Drug/Important Bio-Agent (IBA)

10	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2007
10	Antiviral Agents (Antivirals)IBA 05/2014 - 06/2005
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2013
6	Pharmaceutical PreparationsIBA 08/2021 - 03/2010
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2003
4	ledipasvirIBA 01/2016 - 07/2012
3	Peptides (Polypeptides)IBA 01/2021 - 02/2008
3	CytokinesIBA 01/2017 - 11/2008
3	InterferonsIBA 01/2017 - 10/2007
3	VaccinesIBA 11/2014 - 06/2005
2	LipidsIBA 08/2021 - 02/2008
2	Nucleic AcidsIBA 01/2020 - 05/2007
2	SofosbuvirIBA 01/2019 - 01/2016
2	velpatasvirIBA 01/2019 - 01/2019
2	Caspase 3 (Caspase-3)IBA 04/2015 - 11/2008
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 05/2011
1	GlycogenIBA 08/2021
1	AnthelminticsIBA 08/2021
1	AntioxidantsIBA 08/2021
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 08/2021
1	Praziquantel (Biltricide)FDA Link 08/2021
1	Messenger RNA (mRNA)IBA 08/2021
1	Spider Venoms (Venom, Spider)IBA 01/2021
1	GoldIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 12/2020
1	UbiquitinIBA 12/2020
1	Recombinases (Recombinase)IBA 01/2020
1	EpitopesIBA 01/2020
1	HCV NS3-4A Protease InhibitorsIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	TabletsIBA 01/2019
1	Recombinant ProteinsIBA 11/2018
1	GS-9256IBA 01/2017
1	hepatitis B virus X proteinIBA 01/2017
1	sofosbuvir drug combination ledipasvirIBA 01/2016
1	GS-6620IBA 01/2014
1	Pattern Recognition ReceptorsIBA 01/2014
1	GS-9451IBA 01/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2014
1	PhosphoproteinsIBA 02/2013
1	Inhibitor of Apoptosis ProteinsIBA 12/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2012
1	Peptide LibraryIBA 11/2011
1	Biological ProductsIBA 03/2010
1	Complementary DNA (cDNA)IBA 03/2010
1	cyclophilin BIBA 03/2010
1	Streptozocin (Streptozotocin)FDA Link 11/2008
1	adefovirIBA 01/2008
1	NucleotidesIBA 01/2008
1	Lamivudine (Epivir)FDA Link 01/2008
1	Small Interfering RNA (siRNA)IBA 01/2008
1	Peptide Hydrolases (Proteases)FDA Link 05/2007
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2007
1	Phosphotransferases (Kinase)IBA 02/2005
1	Peptide Initiation Factors (Initiation Factor)IBA 02/2005
1	Double-Stranded RNA (RNA, Double Stranded)IBA 02/2005
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 02/2005
1	eIF-2 Kinase (eIF 2 Kinase)IBA 02/2005

Therapy/Procedure

4	Therapeutics 08/2021 - 01/2008
1	Drug Therapy (Chemotherapy) 11/2014
1	Transplantation 11/2008
1	RNAi Therapeutics 01/2008